Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

online_version

New CMO hops onto Bicycle Therapeutics

September 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bicycle Therapeutics, GSK, Pfizer, biotech, drugs, pharma, pharmaceutical

Bicycle Therapeutics has moved to appoint industry veteran, Maria Koehler, to the position of Chief Medical Officer at the company. …
Appointment
tessa_hilado-web-aug2017-allergan

Allergan’s Executive VP and Chief Financial Officer steps down

September 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, appointment

Allergan has announced that its Executive Vice President and Chief Financial Officer Tessa Hilado intends to step down from her …
Appointment
shutterstock_95714119

Cancer trials underrepresent minorities and elderly, Mayo Clinic says

September 26, 2017 Manufacturing and Production, Research and Development clinical trials, pharma, pharmaceutical

New research conducted by the Mayo Clinic in Minnesota has found participant groups for clinical trials in cancer underrepresent ethnic …
News
pharmafocus_october__cover_2017

The October 2017 issue of Pharmafocus is now live!

September 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMA, Pharmafocus

The October edition of Pharmafocus is now live! You can read it here.
News
shutterstock_57369385

Refining the system: Improving patients’ access to medicine

September 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NCIE, drug access, eams, market access, pharma, pharmaceuticals

The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens …
Feature
allergan

Allergan posts disappointing data in NASH

September 25, 2017 Research and Development, Sales and Marketing Allergan, biotech, drugs, nash, pharma, pharmaceutical

It was only last year that Allergan decided to cough up $1.7 billion to acquire Tobira Therapeutics, with the main …
News
alnylam

Alnylam soars on likely first RNAi treatment approval

September 22, 2017 Medical Communications, Research and Development Alynylam, Sanofi, biotech, drugs, patisran, pharma, pharmaceutical

Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s been a great week for drug research and access, with the first-ever FDA approval of a biosimilar in cancer …
News

New therapy offers triple threat to HIV virus

September 22, 2017 Medical Communications, Research and Development HIV, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …
News
crack_cocaine

Weight loss drugs could be used to treat cocaine addiction

September 21, 2017 Research and Development addiction, cocaine, cocaine addiction, lorcaserin, pharma, pharmaceutical

Researchers at the Boston Medical Center are investigating the potential of utilising weight loss drugs in the treatment of cocaine …
News
novartis_side_building

Novartis scores EU approval in acute myeloid leukaemia and advanced systemic mastocytosis

September 20, 2017 Research and Development, Sales and Marketing EU, Europe, Novartis, acute myeloid leukaemia, advanced systemic mastocytosis, pharma, pharmaceutical

Novartis has announced that its targeted therapy Rydapt (midostaurin) has received EU approval in the two rare cancer indications: newly …
News
bill_gates_-_world_economic_forum_annual_meeting_davos_2008_number2

Gates Foundation invest in Immunocore, warning of infectious disease threat

September 20, 2017 Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, infectious diseases, pharma, pharmaceutical

It has been announced that the Bill & Melina Gates Foundation will invest up to $40 million in UK-based Immunocore …
News
world_health_organization

Antibiotic development is inadequate to meet global resistance threat, WHO warns

September 20, 2017 Research and Development WHO, antibiotic resistance, antimicrobial resistance, pharma, pharmaceutical, world health organization

The World Health Organization (WHO) has released a report indicating that worldwide development of new antibiotics is not keeping pace …
News

BMS’ Opdivo to finally be made available to lung cancer patients in the UK

September 20, 2017 Research and Development, Sales and Marketing Bristol-Myers Squibb, NICE, biotech, drugs, opdivo, pharma, pharmaceutical

It is two and a half years since patients with lung cancer in the US were able to receive Bristol-Myers …
News
gsk_hq_close

GSK gets FDA approval for key triple therapy inhaler

September 20, 2017 Research and Development, Sales and Marketing GSK, Trelegy Ellipta, biotech, drugs, pharma, pharmaceutical

The good news keeps on rolling in for GSK, with the FDA approval for its triple therapy inhaler.
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026